Newsweek takes a look at blood tests for mental illness.
Neurocrine Biosciences said it has submitted a marketing application for valbenazine to treat tardive dyskinesia, a major side effect of antipsychotic drug therapy.
Is non-celiac gluten sensitivity really a thing? Dov Michaeli, MD, PhD, at The Doctor Weighs In, is skeptical.
It isn't only humans who can pass Zika virus to their offspring -- so can mosquitoes. (Reuters)
Inovio's investigational Zika vaccine will be trialed in Puerto Rico. (Philly.com)
Ronald Pies, MD, takes a close look at the "Goldwater Rule" that prohibits psychiatrists from diagnosing mental illnesses on the basis of news reports. (Psychiatric Times)
But then again, Bloomberg quotes analysts saying the brouhaha may not hurt EpiPen's sales substantially.
As concern grows about health plans dropping out of the Affordable Care Act's health insurance exchanges, the Department of Health and Human Services has issued a proposed rule designed to "further promote stable premiums in the individual and small group markets."
Surgeon General Vivik Murthy, MD, joined the fight against opioid abuse with a letter and support for an effort called Turn the Tide.
A novel drug for benign prostatic hypertrophy, fexapotide, met its endpoints in a phase III trial, said manufacturer Nymox.
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us:MPT_editorial@everydayhealthinc.com.
This article and video was published first by MedPageToday Morning Break: Zika in SE Asia & EpiPen Price Probe, a trusted and reliable source for clinical and policy coverage, and free Continuing Medical Education (CME), that directly affects the lives and practices of health care professionals.